Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors

This publication has 14 references indexed in Scilit:

• Clinical Features ofClostridium difficile–Associated Infections and Molecular Characterization of Strains: Results of a Retrospective Study, 2000-2004
  Infection Control & Hospital Epidemiology, 2007
• A Portrait of the Geographic Dissemination of the Clostridium difficile North American Pulsed-Field Type 1 Strain and the Epidemiology of C. difficile-Associated Disease in Quebec
  Clinical Infectious Diseases, 2007
• Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec
  Clinical Infectious Diseases, 2005
• Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK
  Journal of Hospital Infection, 2005
• Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity
  CMAJ : Canadian Medical Association Journal, 2004
• Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut
  Journal of Antimicrobial Chemotherapy, 2003
• Persistence of an Endemic (Toxigenic) Isolate of Clostridium difficile in the Environment of a General Medicine Ward
  Clinical Infectious Diseases, 2000
• Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery ofClostridium difficile
  Journal of Hospital Infection, 2000
• Modification of a PCR Ribotyping Method for Application as a Routine Typing Scheme forClostridium difficile
  Anaerobe, 1996
• An in-vitro model of colonisation resistance to Clostridium difficile infection
  Journal of Medical Microbiology, 1986